Alexandria® — the world’s largest body of medical evidence for clinical decision support and LLM training.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Planning
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Specialists discuss concerns over impact of semaglutide on the eye

Specialists discuss concerns over impact of semaglutide on the eye

by Julia Rudo | Nov 8, 2024 | News and Media

“In a letter to the editor published in the Journal of Diabetes Science and Technology, David C. Klonoff, MD, medical director of the Diabetes Research Institute at Mills-Peninsula Medical Center in San Mateo, California, noted that the findings of the Hathaway...
HLTH24: Atropos Health unveils chat-based AI co-pilot for real-world evidence

HLTH24: Atropos Health unveils chat-based AI co-pilot for real-world evidence

by Julia Rudo | Oct 23, 2024 | News and Media

“Atropos Health’s large language model for real-world evidence is now ready for prime time after a successful beta program. The startup, maker of a real-world data (RWD) platform, announced this week that ChatRWD®, a generative artificial intelligence (AI)...
How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come

How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come

by Julia Rudo | Oct 20, 2024 | News and Media

Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, Dr. Brigham Hyde, CEO and co-founder of...
Should Laparoscopic Sleeve Gastrectomy Be Considered and Reimbursed as an Inpatient or an Outpatient Procedure? A Large Data Comparison of Health Care Use and Hospital Charges

Should Laparoscopic Sleeve Gastrectomy Be Considered and Reimbursed as an Inpatient or an Outpatient Procedure? A Large Data Comparison of Health Care Use and Hospital Charges

by Julia Rudo | Oct 19, 2024 | Publications

An abstract titled, “Should Laparoscopic Sleeve Gastrectomy Be Considered and Reimbursed as an Inpatient or an Outpatient Procedure? A Large Data Comparison of Health Care Use and Hospital Charges” was published in the Journal of the American College of...
Atropos Health Unveils Data Quality ScoreCards for Atropos Evidence™ Network

Atropos Health Unveils Data Quality ScoreCards for Atropos Evidence™ Network

by Julia Rudo | Sep 24, 2024 | News and Media

“The introduction of Data Quality ScoreCards by Atropos Health signals a new standard in real-world data (RWD) benchmarking. This tool enables healthcare organizations to measure and enhance the quality of their data, which is crucial for delivering better...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Planning

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}